Accessibility Menu
 
Ventripoint Diagnostics logo

Ventripoint Diagnostics

(OTC) VPTDF

Current Price$0.07
Market Cap$13.88M
Since IPO (2011)-97%
5 Year-81%
1 Year-26%
1 Month-3%

Ventripoint Diagnostics Financials at a Glance

Market Cap

$13.88M

Revenue (TTM)

$175.62K

Net Income (TTM)

$4.06M

EPS (TTM)

$-0.02

P/E Ratio

-4.18

Dividend

$0.00

Beta (Volatility)

0.60 (Low)

Price

$0.07

Volume

44,035

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.06 - $0.12

VPTDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

Hugh MacNaught

Headquarters

Toronto, ON M6P 1T4, CA

VPTDF Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-21%

Net Income Margin

-23%

Return on Equity

0%

Return on Capital

82%

Return on Assets

-11%

Earnings Yield

-23.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.88M

Shares Outstanding

187.66M

Volume

44.03K

Short Interest

0.00%

Avg. Volume

94.77K

Financials (TTM)

Gross Profit

$95.17K

Operating Income

$4.80M

EBITDA

$4.76M

Operating Cash Flow

$3.39M

Capital Expenditure

$0.00

Free Cash Flow

$3.39M

Cash & ST Invst.

$60.55K

Total Debt

$1.63M

Ventripoint Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$104.30K

+61.7%

Gross Profit

$104.30K

+61.7%

Gross Margin

100.00%

N/A

Market Cap

$13.88M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$752.08K

+39.9%

EBITDA

$616.56K

+47.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.28M

-71.4%

Accounts Receivable

$124.48K

-41.5%

Inventory

$0.00

N/A

Long Term Debt

$140.87K

-89.3%

Short Term Debt

$2.21M

+1657.9%

Return on Assets

-10.77%

N/A

Return on Invested Capital

82.19%

N/A

Free Cash Flow

$68.71K

+90.1%

Operating Cash Flow

$68.71K

+90.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASAPFAurora Spine Corporation
$0.20-2.14%
ALRTFALR Technologies Inc.
$0.02+0.57%
LUFFFHerbal Dispatch Inc.
$0.03+0.00%
BTCYBiotricity, Inc.
$0.25-5.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%

Questions About VPTDF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.